Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Computer Methods and Programs in Biomedicine
|
February 13, 2007
A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models
Ivelina Gueorguieva, Kayode Ogungbenro, Gordon Graham, et al.
Biostatistics (Oxford, England)
|
July 11, 2023
A scalable approach for continuous time Markov models with covariates
Farhad Hatami, Alex Ocampo, Gordon Graham, et al.
Journal of Synchrotron Radiation
|
August 30, 2002
New pressure flow cell to monitor BaSO4 precipitation using synchrotron in situ angle-dispersive X-ray diffraction
Alison Hennessy, Gordon Graham, Jerry Hastings, et al.
British Journal of Clinical Pharmacology
|
October 22, 2009
Population pharmacokinetics and optimal design of paediatric studies for famciclovir
Kayode Ogungbenro, Ivan Matthews, Michael Looby, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 7, 2016
Population pharmacokinetics of IND/GLY (indacaterol/glycopyrronium) in COPD patients
Ivan Demin, Christian Bartels, Gordon Graham, et al.
Muscle & Nerve
|
January 11, 2017
Does partial muscle reinnervation preserve future re-innervation potential?
Jonathan Isaacs, Satya Mallu, Mary Shall, et al.
Plos One
|
March 28, 2014
Mammals of Australia's tropical savannas: a conceptual model of assemblage structure and regulatory factors in the Kimberley region
Ian J Radford, Christopher R Dickman, Antony N Start, et al.
The Journal of Investigative Dermatology
|
July 28, 2007
Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis
Haihui Liao, Alex J Waters, David R Goudie, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
December 1, 2022
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence
Thomas Hach, Kasra Shakeri-Nejad, Marc Bigaud, et al.
CNS Drugs
|
March 2, 2022
Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis
Huixin Yu, Gordon Graham, Olivier J David, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Computer Methods and Programs in Biomedicine
|
February 13, 2007
A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models
Ivelina Gueorguieva, Kayode Ogungbenro, Gordon Graham, et al.
Biostatistics (Oxford, England)
|
July 11, 2023
A scalable approach for continuous time Markov models with covariates
Farhad Hatami, Alex Ocampo, Gordon Graham, et al.
Journal of Synchrotron Radiation
|
August 30, 2002
New pressure flow cell to monitor BaSO4 precipitation using synchrotron in situ angle-dispersive X-ray diffraction
Alison Hennessy, Gordon Graham, Jerry Hastings, et al.
British Journal of Clinical Pharmacology
|
October 22, 2009
Population pharmacokinetics and optimal design of paediatric studies for famciclovir
Kayode Ogungbenro, Ivan Matthews, Michael Looby, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 7, 2016
Population pharmacokinetics of IND/GLY (indacaterol/glycopyrronium) in COPD patients
Ivan Demin, Christian Bartels, Gordon Graham, et al.
Muscle & Nerve
|
January 11, 2017
Does partial muscle reinnervation preserve future re-innervation potential?
Jonathan Isaacs, Satya Mallu, Mary Shall, et al.
Plos One
|
March 28, 2014
Mammals of Australia's tropical savannas: a conceptual model of assemblage structure and regulatory factors in the Kimberley region
Ian J Radford, Christopher R Dickman, Antony N Start, et al.
The Journal of Investigative Dermatology
|
July 28, 2007
Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis
Haihui Liao, Alex J Waters, David R Goudie, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
December 1, 2022
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence
Thomas Hach, Kasra Shakeri-Nejad, Marc Bigaud, et al.
CNS Drugs
|
March 2, 2022
Population Pharmacokinetic-B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis
Huixin Yu, Gordon Graham, Olivier J David, et al.
Page
of 3